Maxcyte (MXCT) Cash from Investing Activities (2020 - 2026)

Maxcyte (MXCT) has reported Cash from Investing Activities for 7 consecutive years, with $6.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 326.92% year-over-year to $6.6 million in Q2 2026; TTM through Jun 2026 was $24.1 million, a 85.17% increase from a year earlier, with the FY2025 full-year figure at $25.9 million, up 274.13% from the prior year.
• Cash from Investing Activities was $6.6 million for Q2 2026 at Maxcyte, up from $2.7 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $194.8 million in Q1 2022 and troughed at -$131.9 million in Q2 2022.
• A 5-year average of $4.0 million and a median of $3.2 million in 2023 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 1141.41% in 2022, down 257.12% in 2022.
• Over 5 years, Cash from Investing Activities stood at -$27.1 million in 2022, then jumped by 84.72% to -$4.1 million in 2023, then soared by 59.77% to -$1.7 million in 2024, then surged by 681.14% to $9.7 million in 2025, then tumbled by 32.14% to $6.6 million in 2026.
• The last three Cash from Investing Activities figures came in at $6.6 million (Q2 2026), $2.7 million (Q1 2026), and $9.7 million (Q4 2025), per Business Quant data.